Search Results
Dr. Morgan on Idecabtagene Vicleucel in Multiple Myeloma
Dr. Voorhees on the Effectiveness of Idecabtagene Vicleucel in Multiple Myeloma
Efficacy of anti-myeloma therapies following relapse on idecabtagene vicleucel
Dr. Landgren on the Clinical Benefit of Idecabtagene Vicleucel in R/R Myeloma
Current and Future Directions for Novel Therapy for Multiple Myeloma: Paul G. Richardson, MD
COVID-19: treating patients with multiple myeloma
KarMMa: idecabtagene vicleucel shows efficacy in high-risk subgroups of R/R myeloma
International Myeloma Workshop 2021 | Daily Update, Part 3 | Newly Diagnosed + Relapsed/Refractory
KarMMa: idecabtagene vicleucel QoL
Myeloma Matters Podcast | Targeted Immunotherapy
Epigenetics and myeloma
Phase II data from the KarMMa trial for relapsed/refractory multiple myeloma
